BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Drug Development

  Preliminary Analyses from Phase 2 Genzyme Corporation Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients Data Show Encouraging Results for a Potential New Front-Line Treatment Approach in AML

  June 3, 2008

   · 

  11 min read
• Drug Development

  Cell Therapeutics, Inc. Release: Paclitaxel Poliglumex (OPAXIO(TM))/Capecitabine Regimen Well Tolerated And Active In Metastatic Breast Cancer; Results Of Phase II Investigator-Sponsored Trial Presented At American Society of Clinical Oncology Show Invest

  June 3, 2008

   · 

  4 min read
• Drug Development

  Rigel Pharmaceuticals, Inc. Release: Preliminary Phase 2 Results of R788 in Lymphoma Show Benefit in Diffuse Large B-Cell and SLL/CLL; Results to be Presented at Lymphoma Meeting in Lugano, Switzerland

  June 3, 2008

   · 

  5 min read
• Drug Development

  Anadys Pharmaceuticals, Inc. Initiates Phase I Clinical Trial of ANA598 Company Developing Non-Nucleoside Polymerase Inhibitor for Treatment of Hepatitis C

  June 3, 2008

   · 

  6 min read
• Policy

  Cephalon, Inc. Files Patent Infringement Lawsuit Against Watson Pharmaceuticals, Inc.

  June 3, 2008

   · 

  4 min read
• Business

  Prof Ian Frazer Appointed to Scientific Advisory Board of Avantogen Limited’s Hawaii Biotech, Inc.

  June 3, 2008

   · 

  1 min read
• FDA

  Watson Pharmaceuticals, Inc. Receives FDA Approval of Potassium Chloride Extended-Release Capsules

  June 3, 2008

   · 

  2 min read
• FDA

  Watson Pharmaceuticals, Inc. Receives Final Approval of Omeprazole Delayed-Release Capsules

  June 3, 2008

   · 

  2 min read
• Drug Development

  TransMolecular, Inc. Reports Positive Results from Phase 1 Trial of 131Iodine-TM601 in Metastatic Melanoma

  June 3, 2008

   · 

  6 min read
• Drug Development

  Generex Biotechnology Corporation Phase I Trial Results for Novel Immunotherapy Vaccine in Breast Cancer Patients; Results Conclude Vaccine is Safe and Well-Tolerated in Patients

  June 3, 2008

   · 

  5 min read